Startups
Upside Biotechnologies is developing a system for growing full thickness skin for the treatment of major burns. Upside uses a combination of a proprietary, specially-designed culture chamber with methods for speeding cellular growth to achieve its superior product.
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 22, 2017 | Upside Biotechnologies Raises NZ$2.3M in Series A Funding | Upside Biotechnologies, an Auckland, New Zealand-based regenerative medicine startup, raised NZ$2.3m in its Series A funding round. The round was led by ICE Angels nominees, which represent investment from both ICE Angels individuals and Tu... |
Reviews 0
FAQ about Upside
What has the press written about Upside?
Parsers VC has collected 2 articles mentioning Upside, among them “Upside Biotechnologies Raises NZ$2.3M in Series A Funding” (Mar 22, 2017).
Is Upside still active?
Yes, Upside is active; its latest activity on Parsers VC dates from Mar 23, 2017.